Literature DB >> 23499424

Transcriptional cofactor TBLR1 controls lipid mobilization in white adipose tissue.

Maria Rohm1, Anke Sommerfeld, Daniela Strzoda, Allan Jones, Tjeerd P Sijmonsma, Gottfried Rudofsky, Christian Wolfrum, Carsten Sticht, Norbert Gretz, Maximilian Zeyda, Lukas Leitner, Peter P Nawroth, Thomas M Stulnig, Mauricio Berriel Diaz, Alexandros Vegiopoulos, Stephan Herzig.   

Abstract

Lipid mobilization (lipolysis) in white adipose tissue (WAT) critically controls lipid turnover and adiposity in humans. While the acute regulation of lipolysis has been studied in detail, the transcriptional determinants of WAT lipolytic activity remain still largely unexplored. Here we show that the genetic inactivation of transcriptional cofactor transducin beta-like-related 1(TBLR1) blunts the lipolytic response of white adipocytes through the impairment of cAMP-dependent signal transduction. Indeed, mice lacking TBLR1 in adipocytes are defective in fasting-induced lipid mobilization and, when placed on a high-fat-diet, show aggravated adiposity, glucose intolerance, and insulin resistance. TBLR1 levels are found to increase under lipolytic conditions in WAT of both human patients and mice, correlating with serum free fatty acids (FFAs). As a critical regulator of WAT cAMP signaling and lipid mobilization, proper activity of TBLR1 in adipocytes might thus represent a critical molecular checkpoint for the prevention of metabolic dysfunction in subjects with obesity-related disorders.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23499424     DOI: 10.1016/j.cmet.2013.02.010

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  26 in total

1.  GPS2/KDM4A pioneering activity regulates promoter-specific recruitment of PPARγ.

Authors:  M Dafne Cardamone; Bogdan Tanasa; Michelle Chan; Carly T Cederquist; Jaclyn Andricovich; Michael G Rosenfeld; Valentina Perissi
Journal:  Cell Rep       Date:  2014-06-19       Impact factor: 9.423

Review 2.  Improved methodologies for the study of adipose biology: insights gained and opportunities ahead.

Authors:  Qiong A Wang; Philipp E Scherer; Rana K Gupta
Journal:  J Lipid Res       Date:  2014-02-16       Impact factor: 5.922

Review 3.  Adipose tissue: between the extremes.

Authors:  Alexandros Vegiopoulos; Maria Rohm; Stephan Herzig
Journal:  EMBO J       Date:  2017-06-16       Impact factor: 11.598

4.  Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity.

Authors:  Yun Sok Lee; Jung-Whan Kim; Olivia Osborne; Da Young Oh; Roman Sasik; Simon Schenk; Ai Chen; Heekyung Chung; Anne Murphy; Steven M Watkins; Oswald Quehenberger; Randall S Johnson; Jerrold M Olefsky
Journal:  Cell       Date:  2014-06-05       Impact factor: 41.582

5.  Exchange Factor TBL1 and Arginine Methyltransferase PRMT6 Cooperate in Protecting G Protein Pathway Suppressor 2 (GPS2) from Proteasomal Degradation.

Authors:  Jiawen Huang; M Dafne Cardamone; Holly E Johnson; Mathieu Neault; Michelle Chan; Z Elizabeth Floyd; Frédérick A Mallette; Valentina Perissi
Journal:  J Biol Chem       Date:  2015-06-12       Impact factor: 5.157

6.  microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis.

Authors:  Roldan M de Guia; Adam J Rose; Anke Sommerfeld; Oksana Seibert; Daniela Strzoda; Annika Zota; Yvonne Feuchter; Anja Krones-Herzig; Tjeerd Sijmonsma; Milen Kirilov; Carsten Sticht; Norbert Gretz; Geesje Dallinga-Thie; Sven Diederichs; Nora Klöting; Matthias Blüher; Mauricio Berriel Diaz; Stephan Herzig
Journal:  EMBO J       Date:  2014-12-15       Impact factor: 11.598

7.  Nuclear Receptors in Energy Metabolism.

Authors:  Alina A Walth-Hummel; Stephan Herzig; Maria Rohm
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

8.  An AMP-activated protein kinase-stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice.

Authors:  Maria Rohm; Michaela Schäfer; Victor Laurent; Bilgen Ekim Üstünel; Katharina Niopek; Carolyn Algire; Oksana Hautzinger; Tjeerd P Sijmonsma; Annika Zota; Dasa Medrikova; Natalia S Pellegata; Mikael Ryden; Agné Kulyte; Ingrid Dahlman; Peter Arner; Natasa Petrovic; Barbara Cannon; Ez-Zoubir Amri; Bruce E Kemp; Gregory R Steinberg; Petra Janovska; Jan Kopecky; Christian Wolfrum; Matthias Blüher; Mauricio Berriel Diaz; Stephan Herzig
Journal:  Nat Med       Date:  2016-08-29       Impact factor: 53.440

Review 9.  Immune cells and metabolic dysfunction.

Authors:  Ashley Eheim; Dasa Medrikova; Stephan Herzig
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

Review 10.  Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.

Authors:  Andreas L Birkenfeld; Gerald I Shulman
Journal:  Hepatology       Date:  2014-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.